Adamis Pharmaceuticals Corp (ADMP)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Adamis Pharmaceuticals Corp (ADMP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011242
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc is a biopharmaceutical company that offers therapies. The company develops and commercializes products in the therapeutic areas of allergy and respiratory diseases. Its pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as insect stings, foods, medications and latex. Adamis also provides pipeline products such as APC-2000 for the treatment of bronchospasms; APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease; and APC-3000, an HFA inhaled nasal steroid product for the treatment of allergic rhinitis. The company provides its products for patients, physicians, and healthcare organizations. It has operations in Phoenix, Arizona. Adamis is headquartered in San Diego, California, the US.

Adamis Pharmaceuticals Corp (ADMP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Adamis Pharmaceuticals Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Adamis Pharmaceuticals Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Adamis Pharmaceuticals Corp, Medical Equipment, Deal Details 10
Partnerships 10
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 10
Equity Offering 11
Adamis Pharma Raises USD17.3 Million in Public Offering of Shares 11
Adamis Pharma Raises USD11 Million in Private Placement of Units 13
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 15
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For US$25.5 Million 16
Adamis Pharmaceuticals Corp – Key Competitors 17
Adamis Pharmaceuticals Corp – Key Employees 18
Adamis Pharmaceuticals Corp – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Product News 20
01/14/2016: Adamis Pharmaceuticals Announces FDA Acceptance of Resubmission of Its Epinephrine Pre-Filled Syringe NDA 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Adamis Pharmaceuticals Corp, Medical Equipment, Key Facts, 2016 2
Adamis Pharmaceuticals Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Adamis Pharmaceuticals Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Adamis Pharmaceuticals Corp, Deals By Market, 2011 to YTD 2017 8
Adamis Pharmaceuticals Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 10
Adamis Pharma Raises USD17.3 Million in Public Offering of Shares 11
Adamis Pharma Raises USD11 Million in Private Placement of Units 13
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 15
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For US$25.5 Million 16
Adamis Pharmaceuticals Corp, Key Competitors 17
Adamis Pharmaceuticals Corp, Key Employees 18
Adamis Pharmaceuticals Corp, Subsidiaries 19

★海外企業調査レポート[Adamis Pharmaceuticals Corp (ADMP)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fubon Insurance Co., Ltd.:企業の戦略的SWOT分析
    Fubon Insurance Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Big Y Foods Inc:企業の戦略・SWOT・財務情報
    Big Y Foods Inc - Strategy, SWOT and Corporate Finance Report Summary Big Y Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Codexis Inc (CDXS)-製薬・医療分野:企業M&A・提携分析
    Summary Codexis Inc (Codexis) is a biotechnology company, which focuses on the development of biocatalysts for commercial scale production of fine chemicals and pharmaceuticals. The company’s product portfolio includes pharmaceutical enzymes and intermediates, active pharmaceutical ingredients (APIs …
  • American Water Works Company, Inc.:企業の戦略・SWOT・財務情報
    American Water Works Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Water Works Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Whiting Petroleum Corp (WLL):企業の財務・戦略的SWOT分析
    Whiting Petroleum Corp (WLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Itau Unibanco Holding SA:企業の戦略・SWOT・財務情報
    Itau Unibanco Holding SA - Strategy, SWOT and Corporate Finance Report Summary Itau Unibanco Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cascade Metrix LLC:企業の製品パイプライン分析
    Summary Cascade Metrix LLC (CMI) is a medical technology company that offers automated POC blood analyzer for critical care. The company offers novel micro-volume IV extension kits, and automated glucose monitoring systems, among others. It also provides a revolutionary ex vivo blood analysis system …
  • Empire Electric Association, Inc.:企業の戦略的SWOT分析
    Empire Electric Association, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Sammons Enterprises Inc:戦略・SWOT・企業財務分析
    Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PCM Inc:戦略・SWOT・企業財務分析
    PCM Inc - Strategy, SWOT and Corporate Finance Report Summary PCM Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • CommInsure:企業の戦略・SWOT・財務情報
    CommInsure - Strategy, SWOT and Corporate Finance Report Summary CommInsure - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • ATLAS Oil Company:石油・ガス:M&Aディール及び事業提携情報
    Summary ATLAS Oil Company (ATLAS) is an oil and gas company that offers fuel supply and logistic services. The company’s services comprise supply, renewable fuels, bulk fueling, fuel on demand, logistics, fixed price contracts, frac site fueling, emergency refuel, crude hauling, transloading and on- …
  • Eversource Energy:発電所・企業SWOT分析
    Eversource Energy – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Oaks Hotels & Resorts Limited:企業の戦略・SWOT・財務分析
    Oaks Hotels & Resorts Limited - Strategy, SWOT and Corporate Finance Report Summary Oaks Hotels & Resorts Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Xcel Energy Inc:企業の発電所・SWOT分析2018
    Xcel Energy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Cathay Pacific Airways Limited:企業のM&A・事業提携・投資動向
    Cathay Pacific Airways Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cathay Pacific Airways Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • HOB Biotech Group Suzhou Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary HOB Biotech Group Suzhou Co Ltd (HOB Biotech) is a manufacturer of allergy and autoimmune in vitro diagnostics. It owns and operates bioclia, bioline, and biolisa. The company’s bioclia is engaged in cutting-edge nanoparticle and chemiluminescent technology, and chemiluminescent immuno assay …
  • Maersk Line AS:企業の戦略的SWOT分析
    Maersk Line AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Realty Income Corporation:企業のM&A・事業提携・投資動向
    Realty Income Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Realty Income Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • PhaseRx Inc (PZRX)-医療機器分野:企業M&A・提携分析
    Summary PhaseRx Inc (PhaseRx), formerly PhaseRx Pharmaceuticals Inc is a healthcare products provider that conducts research and develops RNA nanomedicines for the treatment of orphan diseases. The company discovers and develops drugs based on SMARTT polymer technology, which offers mRNA delivery te …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆